Migraine in Electrohypersensitive Patients

Migraine Clinical Trial

Official title:

Prevalence of Migraine Disease in Electrohypersensitive Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04845152
• Other study ID #: RECHMPL21_0250
• Status: Completed
• Start date: April 30, 2021
• Est. completion date: January 30, 2022

Study information

• Verified date: June 2023
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators propose here by the use of the French version of the migraine disease screening questionnaire (ID Migraine ™) to study the prevalence of migraine disease in a population of electrohypersensitive patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 317
• Est. completion date: January 30, 2022
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Informed Consent

• 18 years or older at the time of informed consent

With all these criteria :

• the perception by the subjects of various non-specific functional symptoms

• the absence of clinical and biological evidence to explain the symptoms

• the attribution by the subjects themselves of these symptoms to exposure to electromagnetic fields, which are themselves diverse

• the symptoms are chronic (more than 3 months)

• the symptoms appear during an exposure to a source of electromagnetic radiation and cease after the exposure is stopped

• the symptoms are reproducible

Exclusion criteria:

• age under 18 years old

Related Conditions & MeSH terms

• Headache
• Migraine
• Migraine Disorders

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Possible migraine attack	With the number of positive response to the French version of the migraine disease screening questionnaire, we are looking for the patients declaring themselves electrohypersensitive if they have had headaches in the last 12 months with characteristics that could evoke a migraine attack.	12 months

External Links

•   Study publication
•   Study publication